ABBVIE INC (ABBV)
US00287Y1091 - Common Stock
ChartMill assigns a Buy % Consensus number of 77% to ABBV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 188.18. This target is 16.36% above the current price.
ABBV was analyzed by 35 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about ABBV.
In the previous month the buy percentage consensus was at a similar level.
ABBV was analyzed by 35 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-29 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-04-29 | Barclays | Maintains | Overweight -> Overweight |
| 2024-03-27 | Barclays | Maintains | Overweight -> Overweight |
| 2024-03-22 | Guggenheim | Maintains | Buy -> Buy |
| 2024-02-06 | Raymond James | Maintains | Outperform |
| 2024-02-06 | Truist Securities | Maintains | Buy -> Buy |
| 2024-02-05 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-02-05 | Barclays | Maintains | Overweight -> Overweight |
| 2024-02-05 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-01-29 | William Blair | Upgrade | Market Perform -> Outperform |
| 2024-01-23 | Barclays | Maintains | Overweight -> Overweight |
| 2023-12-18 | HSBC | Downgrade | Buy -> Hold |
| 2023-12-11 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2023-12-01 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-11-09 | Deutsche Bank | Initiate | Hold |
| 2023-10-30 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2023-10-30 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-09-29 | Raymond James | Initiate | Outperform |
| 2023-07-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-07-25 | William Blair | Initiate | Market Perform |
| 2023-07-14 | HSBC | Initiate | Buy |
| 2023-07-11 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-04-28 | Guggenheim | Maintains | Buy |
| 2023-04-28 | Wells Fargo | Maintains | Overweight |
| 2023-04-28 | Morgan Stanley | Maintains | Overweight |
| 2023-04-10 | Morgan Stanley | Maintains | Overweight |
| 2023-04-05 | Argus Research | Downgrade | Buy -> Hold |
| 2023-03-01 | Guggenheim | Initiate | Buy |
| 2023-02-22 | Wolfe Research | Downgrade | Outperform -> Peer Perform |